Guangxi Wuzhou Zhongheng Group Co Ltd Total Assets
Guangxi Wuzhou Zhongheng Group Co Ltd total assets. Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) holds total assets worth CN¥10.29 Billion CNY (≈ $1.51 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Guangxi Wuzhou Zhongheng Group Co Ltd for the company's overall valuation and market capitalisation.
Total Assets of Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2025)
Total assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2025. This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Guangxi Wuzhou Zhongheng Group Co Ltd stock price today for real-time trading data and today's change.
Guangxi Wuzhou Zhongheng Group Co Ltd - Asset Composition Analysis
Guangxi Wuzhou Zhongheng Group Co Ltd Total Assets Breakdown (December 2025)
Guangxi Wuzhou Zhongheng Group Co Ltd total assets breakdown as of December 2025. Guangxi Wuzhou Zhongheng Group Co Ltd's total assets of CN¥10.29 Billion consist of 52.2% current assets and 47.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 33.8% |
| Accounts Receivable | CN¥411.00 Million | 4.1% |
| Inventory | CN¥639.91 Million | 6.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥401.13 Million | 4.0% |
| Goodwill | CN¥44.95 Million | 0.5% |
Asset Composition Trend (1997–2025)
This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Guangxi Wuzhou Zhongheng Group Co Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangxi Wuzhou Zhongheng Group Co Ltd's current assets represent 52.2% of total assets in 2025, an increase from 49.5% in 1997.
- Cash Position: Cash and equivalents constituted 33.8% of total assets in 2025, up from 4.3% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 10.0% in 1997.
- Asset Diversification: The largest asset category is inventory at 6.4% of total assets.
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Total Assets
Key competitors of Guangxi Wuzhou Zhongheng Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Porton Fine Chemicals Ltd
SHE:300363
|
China | CN¥8.58 Billion |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA
|
India | Rs135.21 Billion |
Guangxi Wuzhou Zhongheng Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.13 | 2.31 | 1.99 |
| Quick Ratio | 1.88 | 2.05 | 1.75 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.96 Billion | CN¥3.61 Billion | CN¥2.48 Billion |
Guangxi Wuzhou Zhongheng Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangxi Wuzhou Zhongheng Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.37 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | -8.3% |
| Total Assets | CN¥10.07 Billion |
| Market Capitalization | $1.02 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Guangxi Wuzhou Zhongheng Group Co Ltd's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guangxi Wuzhou Zhongheng Group Co Ltd's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2025)
The table below shows the annual total assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥10.07 Billion ≈ $1.47 Billion |
-8.31% |
| 2024-12-31 | CN¥10.98 Billion ≈ $1.61 Billion |
-5.89% |
| 2023-12-31 | CN¥11.67 Billion ≈ $1.71 Billion |
-0.73% |
| 2022-12-31 | CN¥11.75 Billion ≈ $1.72 Billion |
-1.16% |
| 2021-12-31 | CN¥11.89 Billion ≈ $1.74 Billion |
-0.71% |
| 2020-12-31 | CN¥11.97 Billion ≈ $1.75 Billion |
+52.83% |
| 2019-12-31 | CN¥7.84 Billion ≈ $1.15 Billion |
+8.22% |
| 2018-12-31 | CN¥7.24 Billion ≈ $1.06 Billion |
+5.48% |
| 2017-12-31 | CN¥6.86 Billion ≈ $1.00 Billion |
+5.77% |
| 2016-12-31 | CN¥6.49 Billion ≈ $949.61 Million |
+5.86% |
| 2015-12-31 | CN¥6.13 Billion ≈ $897.03 Million |
-23.62% |
| 2014-12-31 | CN¥8.03 Billion ≈ $1.17 Billion |
+32.50% |
| 2013-12-31 | CN¥6.06 Billion ≈ $886.44 Million |
+29.98% |
| 2012-12-31 | CN¥4.66 Billion ≈ $681.96 Million |
+19.68% |
| 2011-12-31 | CN¥3.89 Billion ≈ $569.83 Million |
+31.23% |
| 2010-12-31 | CN¥2.97 Billion ≈ $434.23 Million |
+97.23% |
| 2009-12-31 | CN¥1.50 Billion ≈ $220.16 Million |
+43.53% |
| 2008-12-31 | CN¥1.05 Billion ≈ $153.40 Million |
-7.39% |
| 2007-12-31 | CN¥1.13 Billion ≈ $165.63 Million |
+6.66% |
| 2006-12-31 | CN¥1.06 Billion ≈ $155.29 Million |
-34.19% |
| 2005-12-31 | CN¥1.61 Billion ≈ $235.95 Million |
-9.17% |
| 2004-12-31 | CN¥1.78 Billion ≈ $259.77 Million |
+62.22% |
| 2003-12-31 | CN¥1.09 Billion ≈ $160.14 Million |
+39.58% |
| 2002-12-31 | CN¥784.06 Million ≈ $114.73 Million |
+14.25% |
| 2001-12-31 | CN¥686.24 Million ≈ $100.42 Million |
+17.45% |
| 2000-12-31 | CN¥584.27 Million ≈ $85.50 Million |
+77.38% |
| 1999-12-31 | CN¥329.39 Million ≈ $48.20 Million |
-6.09% |
| 1998-12-31 | CN¥350.74 Million ≈ $51.32 Million |
+9.56% |
| 1997-12-31 | CN¥320.12 Million ≈ $46.84 Million |
-- |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for … Read more